Breaking the silence: a cross-sectional study of psychological capital, job embeddedness, and silence behavior in operating room nurses - Scorecard - MDSpire

Breaking the silence: a cross-sectional study of psychological capital, job embeddedness, and silence behavior in operating room nurses

  • By

  • Jinfeng Qi

  • Yu Zhang

  • Qiaomei Cheng

  • Shuai Wang

  • Zhi Zou

  • July 1, 2026

  • 0 min

Share

Clinical Scorecard: Examining the Interplay of Psychological Capital, Job Embeddedness, and Silence Behavior Among Operating Room Nurses: A Cross-Sectional Analysis

At a Glance

CategoryDetail
ConditionSilence Behavior Among Operating Room Nurses
Key MechanismsPsychological Capital and Job Embeddedness
Target PopulationOperating Room Nurses
Care SettingSurgical Care Environment

Key Highlights

  • Moderate levels of silence behavior, psychological capital, and job embeddedness were observed among OR nurses.
  • Silence behavior negatively correlated with psychological capital.
  • Job embeddedness negatively correlated with silence behavior and positively correlated with psychological capital.
  • Job embeddedness partially mediates the relationship between psychological capital and silence behavior.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Breaking the silence: a cross-sectional study of psychological capital, job embeddedness, and silence behavior in operating room nurses

            • by Jinfeng Qi, Yu Zhang, Qiaomei Cheng, Shuai Wang, Zhi Zou

            • July 1, 2026

            Related Content

            STOPGAP II — a national randomized clinical trial for patients with stage 4 gastric cancer

            What starts at UCI Health can help shape the national conversation.

            • June 30, 2026

            • 1 min
            FDA Approves New Treatment for Thyroid Eye Disease

            Phase 3 THRIVE and THRIVE-2 trials supported approval following improvements in proptosis and diplopia in active and chronic disease.

            Contemporary perspectives on metabolic surgery for type 2 diabetes: surgical techniques, outcomes, and complications